-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, researchers examined the clinical characteristics of children and adolescents hospitalized with laboratory-proven severe acute respiratory syndrome (SARS-Cov-2) infection in the United Kingdom, and examined critical care, mortality and multisyscular inflammatory syndrome (MIS-C) risk factors associated with coronavirus disease (COVID-19) in 2019.
researchers collected data from 260 hospitals in England, Wales and Scotland between 17 January and 3 July 2020, during which 651 patients under the age of 19 were treated in 138 hospitals for neo-corona pneumonia, with the main endpoints of the study being critical care, hospital mortality and MIS-C morbidity. the average age of
children is 4.6 years, of which 35 per cent (225 cases) are children under 12 months of age, 56 per cent are men, 57 per cent are white, 12 per cent are Black, 10 per cent are black and 42 per cent (276) have other common diseases.
18 per cent of children received intensive care (116 cases).
of the 627 children in the hospital, 6 (1%) died in hospital, all with underlying co-diseases.
11% of children who met the WHO-MIS-C definition, as early as mid-March, had a higher risk of MIS-C in children under the age of 10-14 (3.23) and black children (2.82) after multi-factor adjustments The risk of intensive care in children was 5 times higher than in the general population (73% vs 15%), and there was no significant increase in the risk of fatigue, headache, muscle pain, sore throat, swollen lymph nodes and platelet counts of less than 150 x 109/L in children with MIS-C, but no deaths occurred in children with MIS-C.
study concluded that the proportion of patients with severe neo-coronary pneumonia was lower in children and adolescents, but some children developed symptoms of multisystric inflammatory syndrome, with different demographic and clinical characteristics than among children in general.
.